Meet our Experts at USCAP!

March 2, 2022
We are looking forward to finally meeting you in person again, on this year’s USCAP, March 21-23rd (USA, CA, Los Angeles)!

We are looking forward to finally meeting you in person again, on this year’s USCAP, March 21-23rd (USA, CA, Los Angeles)! Come to our Booth #1029 at LA Convention Center, meet Felix Faber (CEO), Dr. Andreas Hartlep (COO), Dr. Anil Berger (VP Sales & Marketing) and Claudia Bohnsack (Sr. Product Mgr.) and discuss your needs and our AI solutions for clinical routine diagnostics in digital pathology. With deep workflow integration and whole-slide-image pre-calculation the results are displayed to you without any time delay, so you can completely focus on your diagnosis. With our AI you save time and get unbiased and reproducible results all the time.

Events

Related reading

We invite you to join our VP Sales & Marketing, Dr. Anil Berger, as speaker on this year’s Annual Meeting of the Japanese Society of Digital Pathology on Friday August 20th 2021, 15:00-16:00 JST. He will present data from our study on the robustness of our flagship AI-product BreastIHC against real-life image variability.
Events
8 min read

Join our presentation at JSDP online!

We invite you to join our VP Sales & Marketing, Dr. Anil Berger, as speaker on this year’s Annual Meeting of the Japanese Society of Digital Pathology on Friday August 20th 2021, 15:00-16:00 JST. He will present data from our study on the robustness of our flagship AI-product BreastIHC against real-life image variability.

We invite you to join our VP Sales & Marketing, Dr. Anil Berger, as speaker on this year’s Annual Meeting of the Japanese Society of Digital Pathology on Friday August 20th 2021, 15:00-16:00 JST. He will present data from our study on the robustness of our flagship AI-product BreastIHC against real-life image variability. Included were 200+ specimens balanced for clinical scores, prepared with 3 stainers, digitized on 5 scanners plus 1 microscope camera and evaluated by 10 pathologists with and without AI: Put to the test “in the wild” we show that BreastIHC works out-of-the-box in any laboratory setting.

It detects tumor cells on IHC-slides directly, then classifies them according to the relevant subgroups (per biomarker: Ki-67, ER, PR) and quantifies them in order to give the relevant clinical score(s) for each biomarker.

We invite you to join our CEO, Felix Faber, as one of the Keynote Speakers at the 8th Emirates Pathology and Digital Pathology Conference online on August 11th at 10:55 a.m. BST.
Events
8 min read

Join us at 8EPUGC2021 online!

We invite you to join our CEO, Felix Faber, as one of the Keynote Speakers at the 8th Emirates Pathology and Digital Pathology Conference online on August 11th at 10:55 a.m. BST.

We invite you to join our CEO, Felix Faber, as one of the Keynote Speakers at the 8th Emirates Pathology and Digital Pathology Conference online on August 11th at 10:55 a.m. BST. While we’ll miss the opportunity to meet face-to-face, we look forward to connecting digitally at 8EPUGC2021 (August 10-11 2021)! At this year’s virtual event, let us demonstrate how robust our flagship AI-product BreastIHC works with real-life image variability. It detects tumor cells on IHC-slides directly, then classifies them according to the relevant subgroups (per biomarker: Ki-67, ER, PR) and quantifies them in order to give the clinical score(s) for the respective biomarker.

Put to the test with different stainers and scanners it works out-of-the-box in any laboratory setting.

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting